Sientra traded at $0.53 this Friday September 23rd, increasing $0.01 or 1.91 percent since the previous trading session. Looking back, over the last four weeks, Sientra gained 23.61 percent. Over the last 12 months, its price fell by 90.59 percent. Looking ahead, we forecast Sientra to be priced at 0.52 by the end of this quarter and at 0.47 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
0.53
Daily Change
1.91%
Yearly
-90.59%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Abiomed 245.53 -1.73 -0.70% -29.92%
Align Technology 222.43 4.48 2.06% -69.33%
Cerus 3.49 -0.09 -2.51% -46.96%
Cooper Companies 275.68 1.49 0.54% -37.26%
Dexcom 80.66 -0.30 -0.37% -42.46%
Globus Medical 58.29 0.55 0.95% -28.23%
Integra LifeSciences 43.59 0.20 0.46% -39.61%
J&J 166.72 0.54 0.32% 1.44%
NuVasive 43.62 -0.31 -0.71% -30.94%
OraSure Technologies 3.66 0.07 1.95% -66.45%
Insulet 234.19 -7.06 -2.93% -19.02%
Rockwell Medical 1.27 -0.07 -4.87% 94.46%
Sientra 0.53 0.01 1.91% -90.59%
STAAR Surgical 73.25 -2.27 -3.01% -48.61%
Stryker 206.93 -1.95 -0.93% -25.20%
Teleflex 207.48 -4.40 -2.08% -46.54%
Utah Medical Products 85.35 -1.51 -1.74% -10.49%
Zimmer Biomet Holdings Inc 106.21 -1.80 -1.67% -29.77%

Indexes Price Day Year
USND 10868 -198.88 -1.80% -27.78%

Sientra
Sientra, Inc. is a medical aesthetics company. The Company's primary products are silicone gel breast implants for use in breast augmentation and breast reconstruction procedures, which it offers in over 400 variations of shapes, sizes and textures. The Company sells its breast implants and breast tissue expanders, or breast products to plastic surgeons. Its breast implants are primarily used in elective procedures, which are generally performed on a cash-pay basis. Implant Texture provides texturing on the implant shell that is designed to reduce the incidence of malposition, rotation and capsular contracture. The Company also offers breast tissue expanders for reconstruction procedures predominantly to hospitals and surgery centers, and its BIOCORNEUM scar management products to plastic surgeons, dermatologists and other specialties. The Company's brands also include OPUS, Luxe, Curve, AlloX2, Dermaspan and Softspan.